A citation-based method for searching scientific literature

Federica Meloni, Monica Morosini, Nadia Solari, Ileana Passadore, Caterina Nascimbene, Monique Novo, Marco Ferrari, Marco Cosentino, Franca Marino, Ernesto Pozzi, Anna M Fietta. Hum Immunol 2006
Times Cited: 129







List of co-cited articles
1073 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers.
Gilberto Filaci, Daniela Fenoglio, Marco Fravega, Gianluca Ansaldo, Giacomo Borgonovo, Paolo Traverso, Barbara Villaggio, Alessandra Ferrera, Annalisa Kunkl, Marta Rizzi,[...]. J Immunol 2007
160
31

Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Takashi Tsukishiro, Albert D Donnenberg, Theresa L Whiteside. Cancer Immunol Immunother 2003
102
28

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
Tyler J Curiel, George Coukos, Linhua Zou, Xavier Alvarez, Pui Cheng, Peter Mottram, Melina Evdemon-Hogan, Jose R Conejo-Garcia, Lin Zhang, Matthew Burow,[...]. Nat Med 2004
17

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Yukiko Kiniwa, Yoshihiro Miyahara, Helen Y Wang, Weiyi Peng, Guangyong Peng, Thomas M Wheeler, Timothy C Thompson, Lloyd J Old, Rong-Fu Wang. Clin Cancer Res 2007
241
16

CD28(-) T cells: their role in the age-associated decline of immune function.
Nan-Ping Weng, Arne N Akbar, Jorg Goronzy. Trends Immunol 2009
359
14

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.
Jason M Brenchley, Nitin J Karandikar, Michael R Betts, David R Ambrozak, Brenna J Hill, Laura E Crotty, Joseph P Casazza, Janaki Kuruppu, Stephen A Migueles, Mark Connors,[...]. Blood 2003
681
13

Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
Peter DeLong, Richard G Carroll, Adam C Henry, Tomoyuki Tanaka, Sajjad Ahmad, Michael S Leibowitz, Daniel H Sterman, Carl H June, Steven M Albelda, Robert H Vonderheide. Cancer Biol Ther 2005
84
14

CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype.
Javier G Casado, Rocío Soto, Olga DelaRosa, Esther Peralbo, Maria del Carmen Muñoz-Villanueva, Luis Rioja, José Peña, Rafael Solana, Raquel Tarazona. Cancer Immunol Immunother 2005
49
24

Increased percentage of CD8+CD28- suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas.
Donata Urbaniak-Kujda, Katarzyna Kapelko-Słowik, Dariusz Wołowiec, Jarosław Dybko, Agnieszka Hałoń, Bozena Jaźwiec, Joanna Maj, Alina Jankowska-Konsur, Kazimierz Kuliczkowski. Postepy Hig Med Dosw (Online) 2009
17
70


Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.
Carolina L Montes, Andrei I Chapoval, Jonas Nelson, Vbenosa Orhue, Xiaoyu Zhang, Dan H Schulze, Scott E Strome, Brian R Gastman. Cancer Res 2008
62
19

CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.
Marius Strioga, Vita Pasukoniene, Dainius Characiejus. Immunology 2011
260
12

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Gilberto Filaci, Marco Fravega, Simone Negrini, Francesco Procopio, Daniela Fenoglio, Marta Rizzi, Sabrina Brenci, Paola Contini, Daniel Olive, Massimo Ghio,[...]. Hum Immunol 2004
129
11

Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients.
I V Gruber, S El Yousfi, S Dürr-Störzer, D Wallwiener, E F Solomayer, T Fehm. Anticancer Res 2008
34
32

Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Cheng Chen, Dongdong Chen, Yongkui Zhang, Zhijun Chen, Wangyu Zhu, Binjie Zhang, Zhaoye Wang, Hanbo Le. Int Immunopharmacol 2014
49
22

CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Bülent Karagöz, Oğuz Bilgi, Mahmut Gümüs, Alev Akyol Erikçi, Ozkan Sayan, Orhan Türken, Emin Gökhan Kandemir, Ahmet Oztürk, Mustafa Yaylaci. Med Oncol 2010
59
16

The role of CD8+ T-cell replicative senescence in human aging.
Rita B Effros, Mirabelle Dagarag, Carolyn Spaulding, Janice Man. Immunol Rev 2005
216
10

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Jason D Fontenot, Marc A Gavin, Alexander Y Rudensky. Nat Immunol 2003
9

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
E Y Woo, C S Chu, T J Goletz, K Schlienger, H Yeh, G Coukos, S C Rubin, L R Kaiser, C H June. Cancer Res 2001
885
9



Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4.
C C Chang, R Ciubotariu, J S Manavalan, J Yuan, A I Colovai, F Piazza, S Lederman, M Colonna, R Cortesini, R Dalla-Favera,[...]. Nat Immunol 2002
611
9

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
N Chaput, S Louafi, A Bardier, F Charlotte, J-C Vaillant, F Ménégaux, M Rosenzwajg, F Lemoine, D Klatzmann, J Taieb. Gut 2009
180
9

Cellular senescence: when bad things happen to good cells.
Judith Campisi, Fabrizio d'Adda di Fagagna. Nat Rev Mol Cell Biol 2007
9

Human regulatory T cells induce T-lymphocyte senescence.
Jian Ye, Xingxu Huang, Eddy C Hsueh, Qunyuan Zhang, Chunling Ma, Yanping Zhang, Mark A Varvares, Daniel F Hoft, Guangyong Peng. Blood 2012
79
11

Regulatory functions of CD8+CD28- T cells in an autoimmune disease model.
Nader Najafian, Tanuja Chitnis, Alan D Salama, Bing Zhu, Christina Benou, Xueli Yuan, Michael R Clarkson, Mohamed H Sayegh, Samia J Khoury. J Clin Invest 2003
207
8

Control of regulatory T cell development by the transcription factor Foxp3.
Shohei Hori, Takashi Nomura, Shimon Sakaguchi. Science 2003
8

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
Nicholas J Vogelzang, James J Rusthoven, James Symanowski, Claude Denham, E Kaukel, Pierre Ruffie, Ulrich Gatzemeier, Michael Boyer, Salih Emri, Christian Manegold,[...]. J Clin Oncol 2003
8

Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity.
John S Manavalan, Seunghee Kim-Schulze, Luigi Scotto, Afzal J Naiyer, George Vlad, Paolo C Colombo, Charles Marboe, Donna Mancini, Raffaello Cortesini, Nicole Suciu-Foca. Int Immunol 2004
207
8

Increase of regulatory T cells in the peripheral blood of cancer patients.
Anna Maria Wolf, Dominik Wolf, Michael Steurer, Guenther Gastl, Eberhard Gunsilius, Beatrix Grubeck-Loebenstein. Clin Cancer Res 2003
622
8


Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.
Sheng-Wei Ye, Yu Wang, Danila Valmori, Maha Ayyoub, Yan Han, Xiao-Lan Xu, Ai-Lian Zhao, Li Qu, Sacha Gnjatic, Gerd Ritter,[...]. J Clin Immunol 2006
23
34

Inflamm-aging. An evolutionary perspective on immunosenescence.
C Franceschi, M Bonafè, S Valensin, F Olivieri, M De Luca, E Ottaviani, G De Benedictis. Ann N Y Acad Sci 2000
8

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Udaya K Liyanage, Todd T Moore, Hong-Gu Joo, Yoshiyuki Tanaka, Virginia Herrmann, Gerard Doherty, Jeffrey A Drebin, Steven M Strasberg, Timothy J Eberlein, Peter S Goedegebuure,[...]. J Immunol 2002
8

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.
V Appay, D F Nixon, S M Donahoe, G M Gillespie, T Dong, A King, G S Ogg, H M Spiegel, C Conlon, C A Spina,[...]. J Exp Med 2000
725
8

Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.
Francis Rodier, Jean-Philippe Coppé, Christopher K Patil, Wieteke A M Hoeijmakers, Denise P Muñoz, Saba R Raza, Adam Freund, Eric Campeau, Albert R Davalos, Judith Campisi. Nat Cell Biol 2009
8

T cell exhaustion.
E John Wherry. Nat Immunol 2011
8

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.
Julien Fourcade, Zhaojun Sun, Mourad Benallaoua, Philippe Guillaume, Immanuel F Luescher, Cindy Sander, John M Kirkwood, Vijay Kuchroo, Hassane M Zarour. J Exp Med 2010
819
8

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
8


Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
Jian Ye, Chunling Ma, Eddy C Hsueh, Christopher S Eickhoff, Yanping Zhang, Mark A Varvares, Daniel F Hoft, Guangyong Peng. J Immunol 2013
104
8

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.
Ashley M Miller, Kajsa Lundberg, Volkan Ozenci, Alison H Banham, Magnus Hellström, Lars Egevad, Pavel Pisa. J Immunol 2006
309
7


Malignant mesothelioma.
Bruce W S Robinson, Arthur W Musk, Richard A Lake. Lancet 2005
529
7

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses.
J P J J Hegmans, A Hemmes, H Hammad, L Boon, H C Hoogsteden, B N Lambrecht. Eur Respir J 2006
111
7

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.
Shuang Wei, Ilona Kryczek, Linhua Zou, Ben Daniel, Pui Cheng, Peter Mottram, Tyler Curiel, Andrzej Lange, Weiping Zou. Cancer Res 2005
280
7

Restoring function in exhausted CD8 T cells during chronic viral infection.
Daniel L Barber, E John Wherry, David Masopust, Baogong Zhu, James P Allison, Arlene H Sharpe, Gordon J Freeman, Rafi Ahmed. Nature 2006
7

Immune surveillance of tumors.
Jeremy B Swann, Mark J Smyth. J Clin Invest 2007
824
7

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
WanJun Chen, Wenwen Jin, Neil Hardegen, Ke-Jian Lei, Li Li, Nancy Marinos, George McGrady, Sharon M Wahl. J Exp Med 2003
7

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
Riki Okita, Toshiaki Saeki, Shigemitsu Takashima, Yoshiyuki Yamaguchi, Tetsuya Toge. Oncol Rep 2005
72
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.